Skip to main content

Investors

Ulisse Biomed Group is an integrated biotech group with proprietary technologies, developing diagnostic solutions with a focus on public health, distributed diagnostics and molecular innovation.

About Us

We are technology leaders in distribuited and connected diagnostics


Investors

The Ulysses Biomed Group is an integrated biotech group with proprietary technologies, developing diagnostic solutions with a focus on public health, distributed diagnostics and molecular innovation.


Financial Data


Ulisse Group - Consolidated Financial Statements for the Year Ended 31 December 2024
Download
Ulisse Biomed S.p.A. - Separate financial statements for the year ended 31 December 2024
Download
Half-yearly financial report ended 30 June 2024
Download
Ulisse Group - Consolidated Financial Statements for the Year Ended 31 December 2023
Download
Ulisse Biomed S.p.A. - Separate financial statements for the year ended 31 December 2023
Download
Half-yearly financial report ended 30 June 2023
Download
Balance sheet for the year ending 31 December 2022
Download
Half-yearly financial report ended 30 June 2022
Download
Balance sheet for the year ending 31 December 2021
Download
Half-yearly financial report ended 30 June 2021
Download
Financial Statements for the Year Ended 31 December 2020
Download
Condensed Financial Statements as at 31 December 2019
Download

Investor Relations Manager

Contact

Gabriele Salaris

  • Email
    This email address is being protected from spambots. You need JavaScript enabled to view it.
  • Email
    This email address is being protected from spambots. You need JavaScript enabled to view it.
  • Phone